Immunotherapeutics and Vaccine Research Initiative (IVRI)
Research - Berkeley, California, United States
Immunotherapeutics and Vaccine Research Initiative (IVRI) Employees
Sheikh Dawood
Researcher at Immunotherapeutics and Vaccine Research Initiative (IVRI)
Immunotherapeutics and Vaccine Research Initiative (IVRI) Details
The Immunotherapy and Vaccine Research Initiative (IVRI) is a center for basic and early applied research in immunology, microbial pathogenesis, and vaccinology with the potential to profoundly impact the treatment of human disease. The initiative is founded on the principle that mechanistic research investigating the role of the immune system in infectious disease yields new approaches for treating cancer, and conversely, that studies of cancer immunology yield approaches for vaccines and therapies targeting infectious disease. The IVRI will direct and concentrate UCB researchers, their collaborators, and sponsors towards the shared goal of making ground-breaking discoveries, and furthering these discoveries to develop applications in disease prophylaxis and treatment. IVRI will facilitate communication and collaboration among researchers, streamline access to scientific and financial resources, and promote not only the vision, ideas, accomplishments of its scientists, but also the application of these ideas and findings for the development of new therapies for human diseases. By targeting synergies in the expertise and capabilities of its scientists, and unifying their ingenuity with the objectives of its sponsors, the IVRI seeks to maximize the potential of its UCB researchers and accelerate the pace of discovery and translation.
